Oncogenic inspiration for programmable activators
David Ichikawa1,2, Marcus Noyes1,2
1Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, 435 East 30th Street, New York, NY 10016, USA.
Abstract:
The discovery of regulatory domains has been limited to the investigation of transcription factors and homologous protein sequences. In this issue of Cell Genomics, motivated by an oncogenic protein fusion, Tak et al.1 direct the regulatory potential of a nontraditional effector domain to novel genomic loci with fusions to programmable DNA-binding domains.
Insights
Researchers explored a novel effector domain for gene regulation, moving beyond traditional transcription factors. This study demonstrates directing regulatory potential to new genomic locations using engineered DNA-binding domains.
Area of Science:
- Genomics
- Molecular Biology
- Epigenetics
Background:
- Regulatory domain discovery traditionally focused on transcription factors and homologous protein sequences.
- Oncogenic protein fusions present unique challenges and opportunities for understanding gene regulation.
Discussion:
- This study investigates the regulatory potential of a non-traditional effector domain.
- The research directs this domain to novel genomic loci through fusion with programmable DNA-binding domains.
- This approach expands the toolkit for targeted gene regulation and functional genomics.
Key Insights:
- Demonstrates the successful redirection of a non-traditional effector domain's regulatory function.
- Identifies novel genomic targets for engineered regulatory elements.
- Highlights the potential of fusion proteins in modulating gene expression.
Outlook:
- Future research may explore diverse effector domains for targeted epigenetic modifications.
- This methodology could advance therapeutic strategies for genetic disorders and cancer.
- Further studies will elucidate the precise mechanisms of these engineered regulatory interactions.
Related Concept Videos
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
tRNA Activation


